Safety and efficacy of combined long-acting β-agonists and inhaled corticosteroids vs long-acting β-agonists monotherapy for stable COPD: A systematic review

dc.contributor.authorRodrigo, Gustavo Javier
dc.contributor.authorCastro Rodríguez, José Antonio
dc.contributor.authorPlaza, Vicente
dc.date.accessioned2022-01-10T14:07:58Z
dc.date.available2022-01-10T14:07:58Z
dc.date.issued2009
dc.fuente.origenORCID
dc.identifier.doi10.1378/chest.09-0821
dc.identifier.issn0012-3692
dc.identifier.urihttps://www.doi.org/10.1378/chest.09-0821
dc.identifier.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-70350121951&partnerID=MN8TOARS
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/63163
dc.information.autorucEscuela de medicina ; Castro Rodríguez, José Antonio ; 0000-0002-0708-4281 ; 113247
dc.issue.numeroNo. 4
dc.language.isoen
dc.pagina.final1038
dc.pagina.inicio1029
dc.provenancengjara 2022-01-10 11:07:58
dc.relation.isformatofChest, vol. 136, no. 4 (oct. 2009), pp. 1029-1038.
dc.revistaChest
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherMedicina y salud
dc.titleSafety and efficacy of combined long-acting β-agonists and inhaled corticosteroids vs long-acting β-agonists monotherapy for stable COPD: A systematic review
dc.typeartículo
dc.volumenVol. 136
sipa.codpersvinculados113247
Files